Lercanidipine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
__NOTOC__
__NOTOC__
{{CMG}}
{{CMG}}


==Overview==
==Overview==
Line 37: Line 32:
It is sold under various commercial names including '''Zanidip'''.
It is sold under various commercial names including '''Zanidip'''.


==Further reading==
==Further Reading==
<div class="references-small">
<div class="references-small">
<references/>
<references/>
Line 45: Line 40:
</div>
</div>


==External links==
==External Links==
* {{DiseasesDB|31597}}
* {{DiseasesDB|31597}}


[[Category: Calcium channel blockers]]
[[Category: Calcium channel blockers]]
 
[[Category: Cardiovascular Drugs]]
[[Category: Selective calcium channel blockers with mainly vascular effects]][[Category: Dihydropyridine derivatives]][[Category: Cardiovascular Drugs]]
[[Category:Drug]]
 
[[Category:Pyridines]]
[[Category:Drugs]]
 
[[de:Lercanidipin]]
[[fr:Lercanidipine]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 20:25, 23 July 2014

Lercanidipine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC36H41N3O6
Molar mass611.727 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lercanidipine is a calcium channel blocker of the dihydropyridine class.

It is sold under various commercial names including Zanidip.

Further Reading

  • Lin T, Voon W, Yen H, Huang C, Su H, Lai W, Sheu S (2006). "Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters". Kaohsiung J Med Sci. 22 (4): 177–83. PMID 16679299.
  • Martinez M, Lopes L, Coelho E, Nobre F, Rocha J, Gerlach R, Tanus-Santos J (2006). "Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension". J Cardiovasc Pharmacol. 47 (1): 117–22. PMID 16424795.
  • Agrawal R, Marx A, Haller H (2006). "Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension". J Hypertens. 24 (1): 185–92. PMID 16331117.

External Links